Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Список исп. литературыСкрыть список 1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211-59. 2. Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry 2016;3:171-8. 3. National Research Council (US) and Institute of Medicine (US) Committee on Depression, Parenting Practices, and the Healthy Devel-opment of Children. Depression in parents, parenting, and children: opportunities to improve identification, treatment and prevention. Washington: National Academies Press, 2009. 4. Reupert AE, Maybery DJ, Kowalenko NM. Children whose parents have a mental illness: prevalence, need and treatment. MJA Open 2012;1(Suppl. 1):7-9. 5. Beardslee WR, Gladstone TR, O‘Connor EE. Transmission and prevention of mood disorders among children of affectively ill parents: a review. J Am Acad Child Adolesc Psychiatry 2011;50:1098-109. 6. Bloom DE, Cafiero E, Jané-Llopis E et al. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum, 2011. 7. Liu NH, Daumit GL, Dua T et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry 2017;16:30- 40. 8. Cuijpers P, Vogelzangs N, Twisk J et al. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry 2014;171:453-62. 9. Krueger RF, Hopwood CJ, Wright AG et al. Challenges and strategies in helping the DSM become more dimensional and empirically based. Curr Psychiatry Rep 2014;16:515. 10. Krueger RF, Kotov R, Watson D et al. Progress in achieving quantitative classification of psychopathology. World Psychiatry 2018;17:282- 93. 11. Widiger TA, Samuel DB. Diagnostic categories or dimensions? A question for the Diagnostic and Statistical Manual of Mental Disorders – fifth edition. J Abnorm Psychol 2005;114:494- 504. 12. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013;11:126. 13. Greenberg G. The book of woe: The DSM and the unmaking of psychiatry. New York: Penguin, 2013. 14. Binder PE, Holgersen H, Nielsen GH. What is a “good outcome” in psychotherapy? A qualitative exploration of former patients’ point of view. Psychother Res 2010;20:285-94. 15. Cuijpers P, Karyotaki E, Reijnders M et al. Was Eysenck right after all? A reassessment of the effects of psychotherapy for adult depression. Epidemiol Psychiatr Sci 2019;28:21-30. 16. Mohr DC, Ho J, Hart TL et al. Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Translat Behav Med 2014;4:407-23. 17. Cuijpers P, Berking M, Andersson G et al. A meta-analysis of cognitive behavior therapy for adult depression, alone and in comparison to other treatments. Can J Psychiatry 2013;58:376- 85. 18. Cuijpers P, Cristea IA, Karyotaki E et al. How effective are cognitive behavior therapies for ma-jor depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry 2016;15:245-58. 19. Mayo-Wilson E, Dias S, Mavranezouli I et al. Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry 2014;1:368-76. 20. Barkowski S, Schwartze D, Strauss B et al. Efficacy of group psychotherapy for social anxiety disorder: a meta-analysis of randomized-controlled trials. J Anxiety Disord 2016;39:44-64. 21. Pompoli A, Furukawa TA, Imai H et al. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. Cochrane Database Syst Rev 2016;4:CD011004. 22. Mayo-Wilson E, Montgomery P. Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adults. Cochrane Database Syst Rev 2013;9:CD005330. 23. Cuijpers P, Sijbrandij M, Koole S et al. Psychological treatment of generalized anxiety disorder: a meta-analysis. Clin Psychol Rev 2014;34: 130-40. 24. Bisson JI, Roberts NP, Andrew M et al. Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Da-tabase Syst Rev 2013;12:CD003388. 25. Gerger H, Munder T, Gemperli A et al. Integrating fragmented evidence by network meta-analysis: relative effectiveness of psychological interventions for adults with post-traumatic stress disorder. Psychol Med 2014;44:3151-64. 26. Olatunji BO, Davis ML, Powers MB et al. Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res 2013; 47:33-41. 27. Ost LG, Havnen A, Hansen B et al. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-anal-ysis of studies published 1993-2014. Clin Psychol Rev 2015;40:156-69. 28. Velthorst E, Koeter M, van der Gaag M et al. Adapted cognitive-behavioural therapy required for targeting negative symptoms in schiz-ophrenia: meta-analysis and meta-regression. Psychol Med 2015;45:453-65. 29. Burns AM, Erickson DH, Brenner CA et al. Cognitive-behavioral therapy for medication-resistant psychosis: a meta-analytic review. Psychiatr Serv 2014;65:874-80. 30. Eichner C, Berna F. Acceptance and efficacy of metacognitive training (MCT) on positive symptoms and delusions in patients with schizophrenia: a meta-analysis taking into account important moderators. Schizophr Bull 2016;42: 952-62. 31. Chatterton ML, Stockings E, Berk M et al. Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis. Br J Psychiatry 2017;210:333- 41. 32. Chiang KJ, Tsai JC, Liu D et al. Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: a meta-analysis of randomized controlled trials. PLoS One 2017;12:e0176849. 33. Driessen E, Hollon SD, Bockting CLH et al. Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US National Institutes of Health-funded trials. PLoS One 2015;10:e0137864. 34. Cuijpers P, Smit F, Bohlmeijer ET et al. Is the efficacy of cognitive behaviour therapy and other psychological treatments for adult depression overestimated? A meta-analytic study of publication bias. Br J Psychiatry 2010;196:173-8. 35. Dal-Ré R, Bobes J, Cuijpers P. Why prudence is needed when interpreting articles reporting clinical trials results in mental health. Trials 2017;18:143. 36. Cuijpers P, van Straten A, Bohlmeijer E et al. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010;40: 211-23. 37. Munder T, Brütsch O, Leonhart R et al. Researcher allegiance in psychotherapy outcome research: an overview of reviews. Clin Psychol Rev 2013;33:501-11 38. Leykin Y, DeRubeis RJ. Allegiance in psychotherapy outcome research: separating association from bias. Clin Psychol Sci Pract 2009;16: 4-65. 39. Furukawa TA, Noma H, Caldwell DM et al. Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatr Scand 2014;130:181- 92. 40. Gold SM, Enck P, Hasselmann H et al. Control conditions for randomized trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry 2017;4:725-32. 41. Beck AT, Ward CH, Mendelson M et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71. 42. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62. 43. Cipriani A, Furukawa TA, Salanti G et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391:1357-66. 44. Hunt M. How science takes stock: the story of meta-analysis. New York: Russell Sage Foundation, 1997. 45. Cuijpers P, Li J, Hofmann SG et al. Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis. Clin Psychol Rev 2010;30:768-78. 46. Hill CE, Chui H, Baumann E. Revisiting and reenvisioning the outcome problem in psychotherapy: an argument to include individualized and qualitative measurement. Psychotherapy 2013;50:68-76. 47. Yalom ID. Existential psychotherapy. New York: Basic Books, 1980. 48. Lilienfeld SO, Treadway MT. Clashing diagnostic approaches: DSM-ICD versus RDoC. Annu Rev Clin Psychol 2016;12:435-63. 49. Borsboom D. A network theory of mental disorders. World Psychiatry 2017;16:5-13. 50. Insel T, Cuthbert B, Garvey M et al. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010;167:748-51. 51. Insel TR. The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry. Am J Psychiatry 2014;171: 395-7. 52. Kealy D, Joyce AS, Weber R et al. What the patient wants: addressing patients’ treatment targets in an integrative group psychotherapy programme. Psychol Psychother 2019;92:20- 38. 53. Wampold BE. How important are the common factors in psychotherapy? An update. World Psychiatry 2015;14:270-7. 54. Battle CC, Imber SD, Hoehn-Saric R et al. Target complaints as criteria of improvement. Am J Psychother 1966;20:184-92. 55. Sales CMD, Alves PCG. Patient-centered assessment in psychotherapy: a review of individualized tools. Clin Psychol Sci Pract 2016;23: 265-83. 56. Ashworth M, Shepherd M, Christey J et al. A client-generated psychometric instrument: the development of ‘PSYCHLOPS’. Couns Psy-chother Res 2004;4:27-31. 57. Elliott R, Wagner J, Sales CMD et al. Psychometrics of the Personal Questionnaire: a client-generated outcome measure. Psychol Assess 2016;28:263-78. 58. Weisz JR, Chorpita BF, Frye A et al. Youth Top Problems: using idiographic, consumer-guided assessment to identify treatment needs and to track change during psychotherapy. J Consult Clin Psychol 2011;79:369-80. 59. McLeod J. Qualitative research in counselling and psychotherapy. London: Sage, 2011. 60. Timulak L, Keogh D. The client’s perspective on (experiences of) psychotherapy: a practice friendly review. J Clin Psychol 2017;73:1556-67. 61. Timulak L, McElvaney R. Qualitative meta-analysis of insight events in psychotherapy. Couns Psychol Quart 2013;26:131-50. 62. Saarni SI, Suvisaari J, Sintonen H et al. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 2007;190:326-32. 63. WHOQOL group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organi-zation. Soc Sci Med 1995;41: 1403-9. 64. Kolovos S, Kleiboer A, Cuijpers P. The effect of psychotherapy for depression on quality of life: a meta-analysis. Br J Psychiatry 2016;209:460-8. 65. Linardon J, Brennan L. The effects of cognitive-behavioral therapy for eating disorders on quality of life: a meta-analysis. Int J Eat Disord 2017;50:715-30. 66. Laws KR, Darlington N, Kondel TK. Cognitive behavioural therapy for schizophrenia – outcomes for functioning, distress and quality of life: a meta-analysis. BMC Psychol 2018;6:32. 67. Hofmann SG, Wu JQ, Boettcher H. Effect of cognitive behavioral therapy for anxiety disorders on quality of life: a meta-analysis. J Consult Clin Psychol 2014;82:375–91. 68. Kamenov K, Twomey C, Cabello M et al. The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis. Psychol Med 2017;47:414-25. 69. Bitter NA, Roeg DP, van Nieuwenhuizen C et al. Identifying profiles of service users in housing services and exploring their quality of life and care needs. BMC Psychiatry 2016;16:419. 70. Nieuwenhuijsen K, Faber B, Verbeek JH et al. Interventions to improve return to work in depressed people. Cochrane Database Syst Rev 2014;12:CD006237. 71. Park M, Cuijpers P, van Straten A et al. The effects of psychological treatments of adult depression on social support: a meta-analysis. Cogn Ther Res 2014;38:600-11. 72. Renner F, Cuijpers P, Huibers MJH. The effect of psychotherapy for depression on improvements in social functioning: a meta-analysis. Psychol Med 2013;44:2913-26. 73. Cuijpers P, Weitz E, Karyotaki E et al. The effects of psychological treatment of maternal depression on children and parental functioning: a meta-analysis. Eur Child Adolesc Psychiatry 2014;24:237-45. 74. Cristea IA, Huibers MJ, David D et al. The effects of cognitive behavior therapy for adult depression on dysfunctional thinking: a meta-analysis. Clin Psychol Rev 2015;42:62-71. 75. Bowlby J. A secure base. London: Routledge, 2005. 76. Kohut H. The analysis of the self: a systematic approach to the psychoanalytic treatment of narcissistic personality disorders. New York: International Universities Press, 1971. 77. Leichsenring F, Steinert C, Crits-Christoph P. On mechanisms of change in psychodynamic therapy. Z Psychosom Med Psychother 2018; 64:16-22. 78. Hoffart A, Johnson SU. Psychodynamic and cognitive-behavioral therapies are more different than you think: conceptualizations of mental problems and consequences for studying mechanisms of change. Clin Psychol Sci 2017;5:1070- 86. 79. Frank JD. Persuasion and healing: a comparative study of psychotherapy. Baltimore: Johns Hopkins University Press, 1961. 80. Wampold BE, Imel ZE. The great psychotherapy debate: the evidence for what makes psychotherapy work, 2nd ed. New York: Rout-ledge, 2015. 81. Cuijpers P, Reijnders M, Huibers MJH. The role of common factors in psychotherapy outcome. Annu Rev Clin Psychol 2019;15:207-31. 82. Kazdin AE. Understanding how and why psychotherapy leads to change. Psychother Res 2009;19:418-28. 83. Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol 2007;3:1-27. 84. Sokol DK. “First do no harm” revisited. BMJ 2013;347:f6426. 85. Hadley SW, Strupp HH. Contemporary views of negative effects in psychotherapy. Arch Gen Psychiatry 1976;33:1291-302. 86. Mohr DC. Negative outcome in psychotherapy: a critical review. Clin Psychol Sci Pract 1995; 2:1-27. 87. Berk M, Parker G. The elephant on the couch: side-effects of psychotherapy. Aust N Z J Psychiatry 2009;43:787-94. 88. Lilienfeld SO. Psychological treatments that cause harm. Perspect Psychol Sci 2007;2:53- 70. 89. Barlow DH. Negative effects from psychological treatments: a perspective. Am Psychol 2010;65:13-20. 90. Cuijpers P, Reijnders M, Karyotaki E et al. Negative effects of psychotherapies for adult depression: a meta-analysis of deterioration rates. J Affect Disord 2018;239:138-45. 91. Dimidjian S, Hollon SD. How would we know if psychotherapy were harmful? Am Psychol 2010;65:21-33. 92. Boisvert CM. Negative treatment effects: is it time for a black box warning? Am Psychol 2010; 65:680-1. 93. Rozental A, Andersson G, Boettcher J et al. Consensus statement on defining and measuring negative effects of Internet interventions. Internet Interv 2014;1:12-19. 94. Linden M. How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions. Clin Psychol Psychother 2013;20:286-96. 95. Beyerstein BL. Fringe psychotherapies: the public at risk. Sci Rev Altern Med 2001;5:70-9. 96. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-9. 97. Vittengl JR, Jarrett RB, Weitz E et al. Divergent outcomes in cognitive behavioral therapy and pharmacotherapy for adult depression. Am J Psychiatry 2015;173:481-90. 98. Ebert DD, Donkin L, Andersson G et al. Does Internet-based guided-self-help for depression cause harm? An individual participant data meta-analysis on deterioration rates and its moderators in randomized controlled trials. Psychol Med 2016;46:2679-93. 99. Karyotaki E, Kemmeren L, Riper H et al. Is self-guided internet-based cognitive behavioural therapy (iCBT) harmful? An individual participant data meta-analysis. Psychol Med 2018;48:2456-66. 100. Ophuis RH, Lokkerbol J, Heemskerk SC et al. Cost-effectiveness of interventions for treating anxiety disorders: a systematic review. J Affect Disord 2017;210:1-13. 101. Pari AA, Simon J, Wolstenholme J et al. Economic evaluations in bipolar disorder: a systematic review and critical appraisal. Bipolar Disord 2014;16:557-82. 102. Skapinakis P, Caldwell D, Hollingworth W. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults. Health Technol Assess 2016;20:43. 103. Konnopka A, Leichsenring F, Leibing E et al. Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic re-view. J Affect Disord 2009;114:14-31. 104. Bereza BG, Machado M, Einarson TR. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder. Clin Ther 2009;31:1279-308. 105. Karyotaki E, Tordrup D, Buntrock C et al. Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomized controlled trials. Epidemiol Psychiatr Sci 2017;26:501-16. 106. Donker T, Blankers M, Hedman E et al. Economic evaluations of Internet interventions for mental health: a systematic review. Psychol Med 2015;45:3357-76. 107. Kolovos S, van Dongen JM, Riper H et al. Cost effectiveness of guided Internet-based interventions for depression in comparison with control conditions: an individual-participant data meta-analysis. Depress Anxiety 2018;35:209-19. 108. Prinsen CAC, Vohra S, Rose MR et al. How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline. Trials 2016;17:449. 109. Williamson PR, Altman DG, Blazeby JM et al. Developing core outcome sets for clinical trials: issues to consider. Trials 2012;13:132. 110. Gorst SL, Gargon E, Clarke M et al. Choosing important health outcomes for comparative effectiveness research: an updated review and user survey. PLoS One 2016;11:e0146444.